ZeroChaos Announces 2018 Proven Performers to Honor High-Performance Partners
ZeroChaos, a global provider of workforce management solutions, announced today the 2018 Proven Performers in its Performance Excellence Program. The award recognizes 42 organizations for talent management initiatives that had significant, measurable business impact on ZeroChaos’ customer programs.
“We are thrilled each year by our community of trusted, high-performance partners who support ZeroChaos’ values and are committed to the success of our customer programs,” said Karen Maarouf, vice president of supplier relations for ZeroChaos, “and this year was no different. All of the award recipients are advancing ZeroChaos’ mission of transforming contingent workforce management, and it is our privilege to recognize their outstanding work.”
ZeroChaos’ Performance Excellence program was established in 2016 to foster, recognize, and reward excellence in providing contingent staffing services for ZeroChaos customer programs worldwide. Each year, Proven Performers are identified based on a set of metrics including participation analytics, cycle time, talent quality, program compliance, and more.
“Avispa Technology is thrilled to be recognized as a 2018 Proven Performer by ZeroChaos, our premiere VMS partner, for a third consecutive year,” said Rothman Moncayo, President & CEO for Avispa Technology, “and we are so thankful to ZeroChaos for recognizing our commitment to your programs and for the opportunity to support world-class clients. We value our partnership and always stand ready to serve additional programs.”
The list of award recipients includes:
- Ampcus Inc.
- ASK Staffing, Inc.
- Avispa Technology
- Axelon Services Corp.
- Capital Staffing Solutions
- Career Group Companies
- Catapult Staffing, LLC.
- Collabera
- Cypress HCM
- eTeam, Inc.
- Flexton Inc.
- HCS Healthcare
- Integrated Resources Inc.
- Intelliswift Software Inc.
- IT Optimiser
- Lancesoft
- MATRIX
- MINDLANCE, INC.
- Motion Recruitment Partners
- NESC Staffing, LLC.
- NTT DATA SERVICES
- PDS Tech, Inc.
- Primus Software Corporation
- Pyramid Consulting, Inc.
- Rose International, Inc.
- Solomon Page
- Specialist Staffing Group (U.S. Division of SThree PLC)
- SPECTRAFORCE Technologies, Inc.
- Strom Aviation
- Supplemental Health Care
- Systemart, LLC.
- TalentBurst, Inc.
- Tekberry, Inc.
- Ubertal, Inc.
- Ultimate Staffing Services
- United Global Technologies (UGT)
- USPRO
- VARITE, Inc.
- Vertisystem, Inc.
About ZeroChaos
ZeroChaos is a global provider of workforce management solutions that help organizations achieve greater management and financial control of their workforce and talent supply chains. ZeroChaos’ award-winning solutions, including its vendor-neutral Managed Services Program, enable procurement and human resources to improve visibility into contingent labor spend and talent pools, effectively manage and optimize contingent workforce program performance, and mitigate risks. Headquartered in Orlando, ZeroChaos has global operations in the Americas, Europe, and Asia. For more information visit www.zerochaos.com, follow on Twitter @ZeroChaos, or connect with ZeroChaos on LinkedIn.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180326005038/en/
Contact information
ZeroChaos
Patricia Braa, 602-763-6886
pbraa@zerochaos.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CCM Biosciences Announces Presentation of Data on its First-In-Class AML Drug Program at ASCO 202520.5.2025 23:30:00 EEST | Press release
CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its next-generation FLT3 inhibitor drug program for acute myeloid leukemia (AML) at the 2025 Annual Conference of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3 in Chicago. Acute Myeloid Leukemia (AML) is the most severe form of leukemia with few treatment options, and a malignancy frequently driven by mutations in the FMS-like tyrosine kinase 3 (FLT3) gene. The FLT3 internal tandem duplication (ITD) and tyrosine kinase domain (TKD) mutations, particularly D835 and F691, appear in approximately 30% of AML patients, often leading to poor prognosis and resistance to existing therapies. Gilteritinib (Xospata®; Astellas Pharma, peak annual sales projection: $1.5 billion) and Quizartinib (Vanflyta®; Daiichi Sankyo) are two FDA-approved FLT3 inhibitors, with the former approved only for relapsed/refractory AML and the latter approved o
IonQ Partners with Sweden’s Einride to Develop Quantum Supply Chain and Quantum-Enhanced Logistics for Autonomous Driving Solutions20.5.2025 23:05:00 EEST | Press release
IonQ (NYSE: IONQ), a leading commercial quantum computing and networking company, today announced an investment partnership with Einride, a leading global freight mobility company that provides digital, electric, and autonomous technology to explore how quantum computing can drive the next generation of fleet optimization and logistics. Together, IonQ and Einride will develop quantum applications that address large-scale routing and scheduling problems that have traditionally challenged classical computing. By combining IonQ’s advanced quantum systems with Einride’s expertise in autonomous fleet logistics, the two companies will work to unlock new levels of efficiency, reliability, and sustainability for the global freight industry. “Einride shares our belief that quantum computing will fundamentally reshape and improve how large industries such as transportation and logistics operate,” said Niccolo de Masi, CEO of IonQ. “This partnership is aimed at creating a powerful platform with u
CCM Biosciences Announces Presentation of Data on its First-In-Class NSCLC Drug Program at ASCO 202520.5.2025 22:26:00 EEST | Press release
CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its 4th-generation EGFR inhibitor drug program for non-small cell lung cancer (NSCLC) at the 2025 Annual Conference of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3 in Chicago. NSCLC, which accounts for 80% of lung cancer, is the most common cause of cancer death worldwide. Epidermal growth factor receptor (EGFR)-activating mutations (Del19 or L858R) are major oncogenic drivers of NSCLC. EGFR-positive NSCLC accounts for approximately 30% of all diagnosed cases of NSCLC (a similar market size to PD-L1-positive NSCLC, which is addressed by the world’s top-selling drug, Keytruda®). The current standard of care for EGFR-positive NSCLC is comprised of 3rd-generation inhibitors, most notably Osimertinib (Tagrisso®), whose annual sales exceed $6 billion. Most patients treated by tyrosine kinase inhibitors (TKIs) will eventually develop
NielsenIQ's Chief Technology Officer Mohit Kapoor Named Executive of the Year at Global Tech & AI Awards for Leading NIQ’s AI-Driven Tech Transformation20.5.2025 22:24:00 EEST | Press release
NielsenIQ (NIQ) is proud to announce that Mohit Kapoor, Chief Technology Officer, was named Executive of the Year at the inaugural Global Tech & AI Awards. This honor recognizes Mohit's exceptional leadership and visionary contributions to the tech industry, particularly in the realm of AI-powered consumer intelligence. "I am deeply honored to receive the Executive of the Year award at the Global Tech & AI Awards. This recognition is a testament to the incredible work and dedication of the entire NielsenIQ team,” said Mohit Kapoor, Chief Technology Officer, NIQ. “Together, we have redefined consumer and retail intelligence, leveraging AI to deliver unparalleled insights and drive meaningful change in the industry." Under Mohit's leadership, NIQ has adopted an AI-powered approach to its ambitious digital transformation which included a $400 million technology investment and the migration of its global client base onto Discover– a unified, cloud-based platform that seamlessly integrates
Strategic Partnership Between the Government of Morocco and TAQA Morocco, Nareva, ONEE and the Mohammed VI Investment Fund to Develop Key Power and Water Infrastructures in the Kingdom of Morocco20.5.2025 22:08:00 EEST | Press release
As part of the implementation of the commitments made in the joint declaration between His Majesty King Mohammed VI, may God Assist Him, and His Highness Sheikh Mohamed bin Zayed Al Nahyan, TAQA Morocco, in partnership with Nareva and the Mohammed VI Fund for Investment, has signed three memorandums of understanding and related development agreements with the Government of Morocco and ONEE. These agreements cover the development of structuring projects in the power, water and renewable energy sectors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250520313620/en/ Strategic Partnership Between the Government of Morocco and TAQA Morocco, Nareva, ONEE and the Mohammed VI Investment Fund to Develop Key Power and Water Infrastructures in the Kingdom of Morocco (Photo: AETOSWire) The program aims to strengthen the Kingdom's water and energy sovereignty through the development of flexible natural gas-based power generation capacit
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom